TABLE OF CONTENTS
Volume 67, Issue 5 (May 2005)
Perspectives in Renal Medicine |
Perspectives in Basic Science |
Genetic Disorders – Development |
Hormones – Cytokines – Signalling |
Cell Biology – Immunology – Pathology |
Ion Channels – Membrane Transport – Integrative Physiology |
Vascular Biology – Hemodynamics – Hypertension |
Clinical Nephrology – Epidemiology – Clinical Trials |
Dialysis – Transplantation |
Editorials |
Letters to the Editor |
Nephrology Forum |
International Society of Nephrology
Original Articles
Vascular repair and regulation in kidney disease: Overview
PETER GROSS, HI BAHL LEE and FRANK PISTROSCH
Kidney Int 67: 1651-1653; doi:10.1111/j.1523-1755.2005.00255.x
Endothelial cell dysfunction: The syndrome in making
EDMOND O'RIORDAN, JUN CHEN, SERGEY V BRODSKY, IVA SMIRNOVA, HONG LI and MICHAEL S GOLIGORSKY
Kidney Int 67: 1654-1658; doi:10.1111/j.1523-1755.2005.00256.x
The sources of oxidative stress in the vessel wall
MICHAEL S WOLIN, MANSOOR AHMAD and SACHIN A GUPTE
Kidney Int 67: 1659-1661; doi:10.1111/j.1523-1755.2005.00257.x
Direct detection of reactive oxygen species ex vivo
RALF P BRANDES and MARIANO JANISZEWSKI
Kidney Int 67: 1662-1664; doi:10.1111/j.1523-1755.2005.00258.x
Nitric oxide in chronic renal failure
JENS PASSAUER, FRANK PISTROSCH and ECKHART BÜSSEMAKER
Kidney Int 67: 1665-1667; doi:10.1111/j.1523-1755.2005.00259.x
Glomerular endothelial cell differentiation
BARBARA J BALLERMANN
Kidney Int 67: 1668-1671; doi:10.1111/j.1523-1755.2005.00260.x
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors
CARMEN URBICH and STEFANIE DIMMELER
Kidney Int 67: 1672-1676; doi:10.1111/j.1523-1755.2005.00261.x
Cellular transplantation of nephrons
MARC R HAMMERMAN
Kidney Int 67: 1677-1679; doi:10.1111/j.1523-1755.2005.00262.x
Aldosterone makes human endothelium stiff and vulnerable
HANS OBERLEITHNER
Kidney Int 67: 1680-1682; doi:10.1111/j.1523-1755.2005.00263.x
Renoprotective effect of erythropoietin (EPO): Possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney
DUK-HEE KANG, EUN-YOUNG PARK, EUN SUN YU, YOUNG-SUK LEE and KYUN-IL YOON
Kidney Int 67: 1683; doi:10.1111/j.1523-1755.2005.00264.x
Perspectives in Renal Medicine
Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause?
CAMILLE A JONES, ANDRZEJ S KROLEWSKI, JOHN ROGUS, JAY L XUE, ALLAN COLLINS and JAMES H WARRAM
Kidney Int 67: 1684-1691; doi:10.1111/j.1523-1755.2005.00265.x
Perspectives in Basic Science
Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics?
BASIT JAVAID and RICHARD J QUIGG
Kidney Int 67: 1692-1703; doi:10.1111/j.1523-1755.2005.00266.x
Genetic Disorders – Development
Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele
CARLA G MONICO, SANDRO ROSSETTI, JULIE B OLSON and DAWN S MILLINER
Kidney Int 67: 1704-1709; doi:10.1111/j.1523-1755.2005.00267.x
Transgenic overexpression of prothymosin 
induces development of polycystic kidney disease
KUO-JUNG LI, AI-LI SHIAU, YUAN-YOW CHIOU, YI-TE YO and CHAO-LIANG WU
Kidney Int 67: 1710-1722; doi:10.1111/j.1523-1755.2005.00268.x
See also: Editorial by GATTONEHormones – Cytokines – Signalling
Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure
FERNANDO L MARTIN, TRACY L STEVENS, ALESSANDRO CATALIOTTI, JOHN A SCHIRGER, DANIEL D BORGESON, MARGARET M REDFIELD, ANDREAS LUCHNER and JOHNC BURNETT JR
Kidney Int 67: 1723-1730; doi:10.1111/j.1523-1755.2005.00269.x
Functional diversity of AT2 receptor orthologues in closely related species
YING-HONG FENG, LINGYIN ZHOU, YAN SUN and JANICE G DOUGLAS
Kidney Int 67: 1731-1738; doi:10.1111/j.1523-1755.2005.00270.x
Hyperuricemia induces endothelial dysfunction
UDAY M KHOSLA, SERGEY ZHARIKOV, JENNIFER L FINCH, TAKAHIKO NAKAGAWA, CARLOS RONCAL, WEI MU, KARINA KROTOVA, EDWARD R BLOCK, SHARMA PRABHAKAR and RICHARD J JOHNSON
Kidney Int 67: 1739-1742; doi:10.1111/j.1523-1755.2005.00273.x
Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-
signaling in mesangial cells
CHI YOUNG SONG, BONG CHO KIM, HYE KYOUNG HONG and HYUN SOON LEE
Kidney Int 67: 1743-1752; doi:10.1111/j.1523-1755.2005.00271.x
Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion
DANIELA CUGINI, NADIA AZZOLLINI, ELENA GAGLIARDINI, PAOLA CASSIS, RICCARDO BERTINI, FRANCESCO COLOTTA, MARINA NORIS, GIUSEPPE REMUZZI and ARIELA BENIGNI
Kidney Int 67: 1753-1761; doi:10.1111/j.1523-1755.2005.00272.x
Reactive oxygen species mediate high glucose–induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney
EUN AH LEE, JI YEON SEO, ZONGPEI JIANG, MI RA YU, MIN KYUNG KWON, HUNJOO HA and HI BAHL LEE
Kidney Int 67: 1762-1771; doi:10.1111/j.1523-1755.2005.00274.x
Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury
FLORIAN TÖGEL, JORGE ISAAC, ZHUMA HU, KATHY WEISS and CHRISTOF WESTENFELDER
Kidney Int 67: 1772-1784; doi:10.1111/j.1523-1755.2005.00275.x
Cell Biology – Immunology – Pathology
The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats
KENIA POMPERMAYER, DANIELLE G SOUZA, GIOVANNA G LARA, KÁTIA D SILVEIRA, GEOVANNI D CASSALI, ANDERSON A ANDRADE, CLÁUDIO A BONJARDIM, KÁTIA T PASSAGLIO, JAMIL ASSREUY, FERNANDO Q CUNHA, MARIA APARECIDA R VIEIRA and MAURO M TEIXEIRA
Kidney Int 67: 1785-1796; doi:10.1111/j.1523-1755.2005.00276.x
Structure activity relationships of aristolochic acid analogues: Toxicity in cultured renal epithelial cells
PREMALATHA BALACHANDRAN, FENG WEI, RUI-CHAO LIN, IKHLAS A KHAN and DAVID S PASCO
Kidney Int 67: 1797-1805; doi:10.1111/j.1523-1755.2005.00277.x
Thrombotic microangiopathy associated with the hypereosinophilic syndrome
HELEN LIAPIS, ALBERT K HO, DIANE BROWN, GRAEME MINDEL and GERALD GLEICH
Kidney Int 67: 1806-1811; doi:10.1111/j.1523-1755.2005.00278.x
Antibody blockade of TNF- reduces inflammation and scarring in experimental crescentic glomerulonephritis
SARAH B KHAN, H TERENCE COOK, GURJEET BHANGAL, JENNIFER SMITH, FREDERICK W K TAM and CHARLES D PUSEY
Kidney Int 67: 1812-1820; doi:10.1111/j.1523-1755.2005.00279.x
Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis
DAISUKE SAGA, MINORU SAKATSUME, ASA OGAWA, YUTAKA TSUBATA, YOSHIKATSU KANEKO, TAKESHI KURODA, FUMINORI SATO, JUNYA AJIRO, DAISUKE KONDO, TAKASHI MIIDA, ICHIEI NARITA and FUMITAKE GEJYO
Kidney Int 67: 1821-1829; doi:10.1111/j.1523-1755.2005.00280.x
Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate
GEERT J BEHETS, STEVEN C VERBERCKMOES, LINE OSTE, AN R BERVOETS, MURIELLE SALOMÉ, ALAN G COX, JOHN DENTON, MARC E DE BROE and PATRICK C D'HAESE
Kidney Int 67: 1830-1836; doi:10.1111/j.1523-1755.2005.00281.x
Ion Channels – Membrane Transport – Integrative Physiology
Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback
RUISHENG LIU, OSCAR A CARRETERO, YILIN REN and JEFFREY L GARVIN
Kidney Int 67: 1837-1843; doi:10.1111/j.1523-1755.2005.00282.x
Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1
JIANG LIU, MAN LIANG, LIJUN LIU, DEEPAK MALHOTRA, ZIJIAN XIE and JOSEPH I SHAPIRO
Kidney Int 67: 1844-1854; doi:10.1111/j.1523-1755.2005.00283.x
BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats
ITSURO KAZAMA, RYO HATANO, MARI MICHIMATA, KATSUYA SUZUKI, TOMOHIRO ARATA, MICHIKO SUZUKI, NORIYUKI MIYAMA, AKIRA SATO, SUSUMU SATOMI, YUTAKA EJIMA, SEI SASAKI and MITSUNOBU MATSUBARA
Kidney Int 67: 1855-1867; doi:10.1111/j.1523-1755.2005.00284.x
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells
SANKARIDRUG M PERIYASAMY, JIANG LIU, FERAS TANTA, BESHER KABAK, BRENT WAKEFIELD, DEEPAK MALHOTRA, DAVID J KENNEDY, ALAA NADOOR, OLGA V FEDOROVA, WILLIAM GUNNING, ZIJIAN XIE, ALEXEI Y BAGROV and JOSEPH I SHAPIRO
Kidney Int 67: 1868-1877; doi:10.1111/j.1523-1755.2005.00285.x
Albumin stimulates cell growth, L-arginine transport, and metabolism to polyamines in human proximal tubular cells
NEIL ASHMAN, STEVEN M HARWOOD, JULIUS KIESWICH, DAVID A ALLEN, NORMAN B ROBERTS, A CLAUDIO MENDES-RIBEIRO and MUHAMMAD M YAQOOB
Kidney Int 67: 1878-1889; doi:10.1111/j.1523-1755.2005.00286.x
Vascular Biology – Hemodynamics – Hypertension
Effects of NADPH oxidase inhibitor in diabetic nephropathy
KENSUKE ASABA, AKIHIRO TOJO, MARISTELA LIKA ONOZATO, ATSUO GOTO, MARK T QUINN, TOSHIRO FUJITA and CHRISTOPHER S WILCOX
Kidney Int 67: 1890-1898; doi:10.1111/j.1523-1755.2005.00287.x
Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression
MARIO BONOMINI, ASSUNTA PANDOLFI, NATALIA DI PIETRO, VITTORIO SIROLLI, ANNALISA GIARDINELLI, AGOSTINO CONSOLI, LUIGI AMOROSO, FEDERICO GIZZI, MARIA ANNA DE LUTIIS and MARIO FELACO
Kidney Int 67: 1899-1906; doi:10.1111/j.1523-1755.2005.00288.x
Nitric oxide– and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9
JENS PASSAUER, FRANK PISTROSCH, GRIT LÄSSIG, KAY HERBRIG, ECKHART BÜSSEMAKER, PETER GROSS and INGRID FLEMING
Kidney Int 67: 1907-1912; doi:10.1111/j.1523-1755.2005.00289.x
An extremely high dose of losartan affords superior renoprotection in the remnant model
CLARICE KAZUE FUJIHARA, MARILIZA VELHO, DENISE MARIAAVANCINI COSTA MALHEIROS and ROBERTO ZATZ
Kidney Int 67: 1913-1924; doi:10.1111/j.1523-1755.2005.00290.x
Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells
KOZO IKARASHI, BING LI, MICHIHIRO SUWA, KAZUKO KAWAMURA, TETSUO MORIOKA, JIAN YAO, FAHIMA KHAN, MAKOTO UCHIYAMA and TAKASHI OITE
Kidney Int 67: 1925-1933; doi:10.1111/j.1523-1755.2005.00291.x
Clinical Nephrology – Epidemiology – Clinical Trials
Serial crystalluria determination and the risk of recurrence in calcium stone formers
MICHEL DAUDON, CAROLE HENNEQUIN, GHAZI BOUJELBEN, BERNARD LACOUR and PAUL JUNGERS
Kidney Int 67: 1934-1943; doi:10.1111/j.1523-1755.2005.00292.x
Evolving connectionist system versus algebraic formulas for prediction of renal function from serum creatinine
MARK ROGER MARSHALL, QUN SONG, TIAN MIN MA, STEPHEN GERARD MACDONELL and NIKOLA KIRILOV KASABOV
Kidney Int 67: 1944-1954; doi:10.1111/j.1523-1755.2005.00293.x
Anemia is a new complication in Fabry disease: Data from the Fabry Outcome Survey
JULIA KLEINERT, FRANÇOIS DEHOUT, ANDREAS SCHWARTING, ABELARDO GARCÍA DE LORENZO, ROBERTA RICCI, CHRISTOPH KAMPMANN, MICHAEL BECK, UMA RAMASWAMI, ALES LINHART, ANDREAS GAL, GUNNAR HOUGE, URS WIDMER , ATUL MEHTA and GERE SUNDER-PLASSMANN
Kidney Int 67: 1955-1960; doi:10.1111/j.1523-1755.2005.00294.x
Occupational exposure in ANCA-positive patients: A case-control study
SÉVERINE BEAUDREUIL, GÉRARD LASFARGUES, LAURENCE LAUÉRIERE, ZEN EL GHOUL, FLORENCE FOURQUET, CÉDRIC LONGUET, JEAN-MICHEL HALIMI, HUBERT NIVET and MATTHIAS BÜCHLER
Kidney Int 67: 1961-1966; doi:10.1111/j.1523-1755.2005.00295.x
The association between atherosclerotic risk factors and renal function in the general population
JACOBIEN C VERHAVE, HANS L HILLEGE, JOHANNES G M BURGERHOF, RON T GANSEVOORT, DICK DE ZEEUW, PAUL E DE JONG and PREVEND S
Kidney Int 67: 1967-1973; doi:10.1111/j.1523-1755.2005.00296.x
Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects
PIERRE FESLER, JEAN RIBSTEIN, GUILHEM DU CAILAR and ALBERT MIMRAN
Kidney Int 67: 1974-1979; doi:10.1111/j.1523-1755.2005.00297.x
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B12 in kidney transplant recipients
WOLFGANG C WINKELMAYER, ANDREA HUBER, OSWALD F WAGNER, WALTER H HÖRL, GERE SUNDER-PLASSMANN and MANUELA FÖDINGER
Kidney Int 67: 1980-1985; doi:10.1111/j.1523-1755.2005.00298.x
Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study
ARIF ASIF, FLORIN N GADALEAN, DONNA MERRILL, GAUTAM CHERLA, CRISTIAN D CIPLEU, DAVID L EPSTEIN and DAVID ROTH
Kidney Int 67: 1986-1992; doi:10.1111/j.1523-1755.2005.00299.x
Circulating vitamin E, transforming growth factor 1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes
KARIMA ZITOUNI, DIANE D HARRY, JAFFAR NOUROOZ-ZADEH, D JOHN BETTERIDGE and KENNETH A EARLE
Kidney Int 67: 1993-1998; doi:10.1111/j.1523-1755.2005.00300.x
Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant
CHIRAG R PARIKH, PETER MCSWEENEY and ROBERT W SCHRIER
Kidney Int 67: 1999-2005; doi:10.1111/j.1523-1755.2005.00301.x
Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study
GIUSEPPE VEZZOLI, LAURA SOLDATI, TERESA ARCIDIACONO, ANNALISA TERRANEGRA, RITA BIASION, COSIMO ROBERTO RUSSO, FULVIO LAURETANI, STEFANIA BANDINELLI, BENEDETTA BARTALI, ANTONIO CHERUBINI, DANIELE CUSI and LUIGI FERRUCCI
Kidney Int 67: 2006-2014; doi:10.1111/j.1523-1755.2005.00302.x
Dialysis – Transplantation
Clinical impact of preexisting vascular calcifications on mortality after renal transplantation
DOMINGO HERNÁNDEZ, MARGARITA RUFINO, SERGIO BARTOLOMEI, ANA GONZÁLEZ-RINNE, VÍCTOR LORENZO, MARIAN COBO and ARMANDO TORRES
Kidney Int 67: 2015-2020; doi:10.1111/j.1523-1755.2005.00303.x
Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse
JIE NI, YVETTE CNOPS, HUGUETTE DEBAIX, ISABELLE BOISDÉ, JEAN-MARC VERBAVATZ and OLIVIER DEVUYST
Kidney Int 67: 2021-2031; doi:10.1111/j.1523-1755.2005.00304.x
Minimal and optimal peritoneal Kt/V targets: Results of an anuric peritoneal dialysis patient's survival analysis
WAI-KEI LO, SING-LEUNG LUI, TAK-MAO CHAN, FU-KEUNG LI, MAN-FAI LAM, KAI-CHUNG TSE, SYDNEY CHI-WAI TANG, CINDY BO-YING CHOY and KAR-NENG LAI
Kidney Int 67: 2032-2038; doi:10.1111/j.1523-1755.2005.00305.x
A prospective randomized study for prevention of postrenal transplantation bone loss
AMGAD E EL-AGROUDY, AMR A EL-HUSSEINI, MOHARAM EL-SAYED, TAREK MOHSEN and MOHAMED A GHONEIM
Kidney Int 67: 2039-2045; doi:10.1111/j.1523-1755.2005.00306.x
Insulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients
ARJA SIIRTOLA, MARJATTA ANTIKAINEN, MARJA ALA-HOUHALA, ANNA-MAIJA KOIVISTO, TIINA SOLAKIVI, SUVI M VIRTANEN, HANNU JOKELA, TERHO LEHTIMÄKI, CHRISTER HOLMBERG and MATTI K SALO
Kidney Int 67: 2046-2055; doi:10.1111/j.1523-1755.2005.00307.x
Validation of estimates of total body water in pediatric dialysis patients by deuterium dilution
SUSAN R MENDLEY, NANCY L MAJKOWSKI and DALE A SCHOELLER
Kidney Int 67: 2056-2062; doi:10.1111/j.1523-1755.2005.00308.x
Editorials
Prothymosin alpha as a cystogen
VINCENT H GATTONE II
Kidney Int 67: 2063-2064; doi:10.1111/j.1523-1755.2005.00313.x
See also: Genetic Disorders – Development by LI et al.Letters to the Editor
High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism
MALIK TOUAM, VICTORIO MENOYO, DAVID ATTAF, HENRI-EMILE THEBAUD and TILMAN B DRÜEKE
Kidney Int 67: 2065; doi:10.1111/j.1523-1755.2005.310_1.x
See also: Letter to the Editor byReply from the Author
Kidney Int 67: 2065-2066; doi:10.1111/j.1523-1755.2005.310_2.x
See also: Letter to the Editor by TOUAM et al.Association of reduced red blood cell deformability and diabetic nephropathy
LAURE REBSOMEN and MICHEL TSIMARATOS
Kidney Int 67: 2066; doi:10.1111/j.1523-1755.2005.310_3.x
See also: Letter to the Editor by BROWN et al.Reply from the Authors
CLINTON D BROWN, HALIM S GHALI, ZHONG H ZHAO, LORRAINE L THOMAS and ELI A FRIEDMAN
Kidney Int 67: 2066-2067; doi:10.1111/j.1523-1755.2005.310_4.x
See also: Letter to the Editor by REBSOMEN & TSIMARATOSReverse epidemiology of blood pressure in dialysis patients
KAMYAR KALANTAR-ZADEH, RYAN D KILPATRICK and JOEL D KOPPLE
Kidney Int 67: 2067; doi:10.1111/j.1523-1755.2005.310_5.x
See also: Letter to the Editor by AGARWALReply from the Authors
RAJIV AGARWAL
Kidney Int 67: 2067-2068; doi:10.1111/j.1523-1755.2005.310_6.x
See also: Letter to the Editor by KALANTAR-ZADEH et al.Nephrology Forum
Management of advanced renal cancer
MICHAEL B ATKINS Principal discussant:
Kidney Int 67: 2069-2082; doi:10.1111/j.1523-1755.2005.00309.x
